Amarin Pharmaceuticals Ireland Limited
Patents = 140
Trademarks = 16
Forward Citations = 4,459
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
21 inventors (with patents filed for the assignee):
Amarin Pharmaceuticals Ireland Limited is a biopharmaceutical company that is focused on the development and commercialization of therapeutics for the treatment of cardiovascular diseases. Their flagship product, Vascepa, is an FDA-approved prescription medicine for reducing cardiovascular risk in certain patients. Amarin Pharmaceuticals Ireland Limited is committed to improving patient outcomes and transforming the lives of individuals affected by cardiovascular diseases.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com